Bosnia and Herzegovina vs South Africa: Share of S. aureus infections resistant to methicillin
Bosnia and Herzegovina
26.5%
in 2022
South Africa
16.5%
in 2022
Bosnia and Herzegovina rank
23rd
South Africa rank
26th
Share of S. aureus infections resistant to methicillin over time
- Bosnia and Herzegovina
- South Africa
How they compare
Bosnia and Herzegovina currently reports 26.5% against 16.5% in South Africa, a difference of 10.0%.
That makes Bosnia and Herzegovina's figure about 1.6 times South Africa's.
The two have swapped places 3 times across 7 shared years of data; in 2016 it was South Africa ahead.
Bosnia and Herzegovina ranks 23rd and South Africa ranks 26th of 45 countries.
Across the 2 decades both report, Bosnia and Herzegovina averaged higher in 1 and South Africa in 1.
Head to head by decade
| Decade | Bosnia and Herzegovina | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.7% | 23.7% | 6.0% | South Africa |
| 2020s | 23.5% | 17.6% | 5.9% | Bosnia and Herzegovina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Bosnia and Herzegovina or South Africa?
- Bosnia and Herzegovina, at 26.5% against 16.5% in South Africa as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Bosnia and Herzegovina and South Africa?
- 10.0%, with Bosnia and Herzegovina ahead.
- How many years of comparable data are there for Bosnia and Herzegovina and South Africa?
- 7 years are reported by both, from 2016 to 2022.
- How do Bosnia and Herzegovina and South Africa rank globally for share of s. aureus infections resistant to methicillin?
- Bosnia and Herzegovina ranks 23rd and South Africa ranks 26th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).